Revolution and Summit Shares Rise on Cancer Trial Data
Shares of Revolution Medicines and Summit Therapeutics rose on Monday after experimental cancer treatments showed significant survival benefits. Revolution's pancreatic cancer pill doubled survival rates versus chemotherapy, while Summit's lung cancer therapy improved outcomes by 15%.
Xurve View
洞察:
Xurve View
REVOLUTION MEDICINES INC and SUMMIT THERAPEUTICS INC shares rose on Monday after experimental cancer drugs improved patient survival in late-stage trials. Revolution's pancreatic cancer pill doubled survival rates, while Summit's lung cancer therapy increased life expectancy by 15%. The clinical wins drove investor interest in advanced-stage cancer treatments.
